Skip to main content

Advertisement

Table 1 Patient details

From: Assessment of target-mediated uptake with immuno-PET: analysis of a phase I clinical trial with an anti-CD44 antibody

Patient Gender Tumour type CD44 expression (IHC)
Membrane score H-score Biopsy location
1 F Squamous cell carcinoma cervix 3 285 Lung
2 M Adenocarcinoma oesophagus 2 (focal) 30 Oesophagus
3 M Colorectal carcinoma 2 (focal) 25 Liver
4 M Melanoma 3 250 Liver
5 M Colorectal carcinoma 2 130 Peritoneal
6 F Squamous cell carcinoma cervix 2 (focal) 65 Cervix
7 M Basaloid carcinoma tonsil 3 135 Lung
8 M Squamous cell carcinoma oesophagus 3 210 Neck left
9 M Colorectal carcinoma 2 85 Liver
10 M Cholangiocarcinoma 3 200 Liver
11 F Squamous cell carcinoma ear canal 3 260 Neck left
12 M Colorectal carcinoma 2 (focal) 35 Liver
13 M Colorectal carcinoma 3 218 Liver